Top

Gepubliceerd in:

2009 | OriginalPaper | Hoofdstuk

17 Levercysten

Auteurs : L. van Keimpema, D.B. de Koning, Prof.dr. J.P.H. Drenth

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Hoewel symptomatische levercysten niet vaak voorkomen, is het wel van belang om de verschillende vormen van elkaar te onderscheiden (kader) omdat de aanpak en behandeling anders kan zijn. Het volgende hoofdstuk hoopt hierbij een leidraad in de praktijk te bieden.

vorige hoofdstuk 16 Levertumoren

volgende hoofdstuk 18 Parasitaire, bacteriële en schimmelinfecties van de lever

Qian Q, Li A, King BF, Kamath PS, Lager DJ, Huston J III, et al. Clinical profile of autosomal dominant polycystic liver disease. Hepatology 2003;37(1):164–171.PubMedCrossRef

Vuitton DA, Wen H. Treatment of cystic echinococcosis: a combination of general goals and rules, individual decisions and indications. Neth J Med 2007;65(3): 86–88.PubMed

Hai S, Hirohashi K, Uenishi T, Yamamoto T, Shuto T, Tanaka H, et al. Surgical management of cystic hepatic neoplasms. J Gastroenterol 2003;38(8):759–764.PubMedCrossRef

Ong AC, Harris PC. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int 2005;67(4):1234–1247.PubMedCrossRef

Rizk D, Chapman AB. Cystic and inherited kidney diseases. Am J Kidney Dis 2003;42(6):1305–1317.PubMedCrossRef

Ecder T, Schrier RW. Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. Expert Rev Cardiovasc Ther 2004;2(3):369–374.PubMedCrossRef

Drenth JP, Morsche RH te, Smink R, Bonifacino JS, Jansen JB. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat Genet 2003;33(3):345–347.PubMedCrossRef

Davila S, Furu L, Gharavi AG, Tian X, Onoe T, Qian Q, et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 2004;36(6):575–577.PubMedCrossRef

Drenth JP, Martina JA, van de KR, Bonifacino JS, Jansen JB. Polycystic liver disease is a disorder of cotranslational protein processing. Trends MolMed 2005;11(1): 37–42.CrossRef

10.

Everson GT, Taylor MR, Doctor RB. Polycystic disease of the liver. Hepatology 2004;40(4):774–782.PubMedCrossRef

11.

Sherstha R, McKinley C, Russ P, Scherzinger A, Bronner T, Showalter R, et al. Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 1997;26(5):1282–1286.PubMed

12.

Tikkakoski T, Makela JT, Leinonen S, Paivansalo M, Merikanto J, Karttunen A, et al. Treatment of symptomatic congenital hepatic cysts with single-session percutaneous drainage and ethanol sclerosis: technique and outcome. J Vasc Interv Radiol 1996;7(2):235–239.PubMedCrossRef

13.

Keimpema L van, Koning DB de, Strijk SP, et al. Aspiration- sclerotherapy results in effective control of liver volume in patients with liver cysts. Dig Dis Sci 2008; 53:2251–2257.PubMedCentralPubMedCrossRef

14.

Martin IJ, McKinley AJ, Currie EJ, Holmes P, Garden OJ. Tailoring the management of nonparasitic liver cysts. Ann Surg 1998;228(2):167–172.PubMedCentralPubMedCrossRef

15.

Keimpema L van, Ruurda JP, Ernst MF, Geffen HJ van, Drenth JP. Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%. J Gastrointest Surg 2008;12(3):477–482.PubMedCrossRef

16.

Arnold HL, Harrison SA. New advances in evaluation and management of patients with polycystic liver disease. Am J Gastroenterol 2005;100(11):2569–2582.PubMedCrossRef

17.

Everson GT, Taylor MR. Management of polycystic liver disease. Curr Gastroenterol Rep 2005;7(1):19–25.PubMedCrossRef

18.

Keimpema L van, Man RA de, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008;57:1338–1339.PubMedCrossRef

19.

Keimpema L van, Nevens F, Vanslembrouck R, et al. Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2009;in druk.

20.

Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, et al. Sirolimus Reduces Polycystic Liver Volume in ADPKD Patients. J Am Soc Nephrol 2008;19(3):631–638.PubMedCentralPubMedCrossRef

Titel: 17 Levercysten
Auteurs: L. van Keimpema
D.B. de Koning
Prof.dr. J.P.H. Drenth
Uitgeverij: Bohn Stafleu van Loghum
Boek: Leverziekten
Print ISBN: 978-90-313-7436-6

Elektronisch ISBN: 978-90-313-7437-3

Copyright: 2009
DOI: https://doi.org/10.1007/978-90-313-7437-3_17

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen